Liver disease in mitochondrial disorders

Seminars in Liver Disease

Volumn 27, Issue 3, 2007, Pages 259-273

  Lee, Way S ^a,b   Sokol, Ronald J ^b,c  

^a UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c CHILDREN S HOSPITAL   (United States)

Author keywords

Genetics; Mitochondrial hepatopathies; Pathogenesis

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CARNITINE; CREATINE; CYTOCHROME C OXIDASE; DICHLOROACETIC ACID; IDEBENONE; MENADIONE; MITOCHONDRIAL DNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); RIBOFLAVIN; SUCCINIC ACID; THIAMINE; UBIDECARENONE; UBIQUINOL CYTOCHROME C REDUCTASE;

ALPERS DISEASE; BCS1 GENE; CHOLESTASIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DGUOK GENE; DISEASE CLASSIFICATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVITY; FATTY LIVER; GENE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; INTESTINE VILLUS ATROPHY; LACTIC ACIDEMIA; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FAILURE; LIVER TRANSPLANTATION; MITOCHONDRIAL DNA DEPLETION SYNDROME; MPV17 GENE; NAVAJO NEUROHEPATOPATHY; NEUROMUSCULAR DISEASE; NEWBORN PERIOD; PATHOGENESIS; PEARSON SYNDROME; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY CHAIN; REVIEW; SCO1 GENE; SCREENING TEST;

CHILD; HUMANS; INFANT, NEWBORN; LIVER DISEASES; MITOCHONDRIA; MITOCHONDRIAL DISEASES;

EID: 34548141732     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-985071     Document Type: Review

References (83)

1. Chinnery PF, DiMauro S. Mitochondrial hepatopathies. J Hepatol 2005;43:207-209
2. Sokol RJ, Treem WR. Mitochondria and childhood liver diseases. J Pediatr Gastroenterol Nutr 1999;28:4-16
3. DiMauro S, Schon EA. Mitochondrial respiratory-chain diseases. N Engl J Med 2003;348:2656-2668
4. Johns DR. Mitochondrial DNA and disease. N Engl J Med 1995;333:638-644
5. Morris AA, Taanman JW, Blake J, et al. Liver failure associated with mitochondrial DNA depletion. J Hepatol 1998;28:556-563
6. Labarthe F, Dobbelaere D, Devisme L, et al. Clinical, biochemical and morphological features of hepatocerebral syndrome with mitochondrial DNA depletion due to deoxyguanosine kinase deficiency. J Hepatol 2005;43:333-341
7. Sutovsky P, Moreno RD, Ramalho-Santos J, Dominko T, Simerly C, Schatten G. Ubiquitin tag for sperm mitochondria. Nature 1999;402:371-372
8. Sutovsky P, Van Leyen K, McCauley T, Day BN, Sutovsky M. Degradation of paternal mitochondria after fertilization: implications for heteroplasmy, assisted reproductive technologies and mtDNA inheritance. Reprod Biomed Online 2004;8:24-33
9. Skladal D, Halliday J, Thornburn DR. Minimum birth prevalence of mitochondrial respiratory chain disorders in children. Brain 2003;126:1905-1912
10. Darin N, Oldfors A, Moslemi AR, Holme E, Tulinius M. The incidence of mitochondrial encephalomyopathies in childhood: clinical features and morphological, biochemical, and DNA abnormalities. Ann Neurol 2001;49:377-383
11. Cormier-Daire V, Chretien D, Rustin P, et al. Neonatal and delayed-onset liver involvement in disorders of oxidative phosphorylation. J Pediatr 1997;130:817-822
12. Garcia-Cazorla A, De Lonlay P, Nassogne MC, Rustin P, Touati G, Saudubray JM. Long-term follow-up of neonatal mitochondrial cytopathies: a study of 57 patients. Pediatrics 2005;116:1170-1177
13. Holve S, Hu D, Shub M, Tyson RW, Sokol RJ. Liver disease in Navajo neuropathy. J Pediatr 1999;135:482-493
14. Leonard JV, Shapiro AHV. Mitochondrial respiratory chain disorders. I: mitochondrial DNA defects. Lancet 2000;355:299-304
15. Von Kleist-Retzow JC, Cormier-Daire V, Viot G, et al. Antenatal manifestations of mitochondrial respiratory chain deficiency. J Pediatr 2003;143:208-212
16. Moraes CT, Shanske S, Tritschler HJ, et al. mtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases. Am J Hum Genet 1991;48:492-501
17. Bakker HD, Scholte HR, Dingemans KP, Spelbrink JN, Wijburg FA, Van der Bogert C. Depletion of mitochondrial deoxyribonucleic acid in a family with fatal neonatal liver disease. J Pediatr 1996;128:683-687
18. Narkewicz MR, Sokol RJ, Beckwith B, Sondheimer J, Silverman A. Liver involvement in Alpers disease. J Pediatr 1991;119:260-267
19. Boyd SG, Harden A, Egger J, Pampiglione G. Progressive neuronal degeneration of childhood with liver disease ("Alpers' disease"): characteristic neurophysiological features. Neuropediatrics 1986;17:75-80
20. Tzoulis C, Engelsen BA, Telstad W, et al. The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases. Brain 2006;129:1685-1692
21. Harding BN. Progressive neuronal degeneration of childhood with liver disease (Alpers-Huttenlocher syndrome): a personal review. J Child Neurol 1990;5:273-287
22. Egger J, Harding BN, Boyd SG, Wilson J, Erdohazi M. Progressive neuronal degeneration of childhood (PNDC) with liver disease. Clin Pediatr (Phila) 1987;26:167-173
23. Gauthier-Villars M, Landrieu P, Cormier-Daire V, et al. Respiratory chain deficiency in Alpers syndrome. Neuropediatrics 2001;32:150-152
24. Pearson HA, Lobel JS, Kocoshis SA, et al. A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. J Pediatr 1979;95:976-984
25. Morikawa Y, Matsuura N, Kakudo K, Higuchi R, Koike M, Kobayashi Y. Pearson's marrow/pancreas syndrome: a histological and genetic study. Virchows Arch A Pathol Anat Histopathol 1993;423:227-231
26. Krahenbuhl S, Kleinle S, Henz S, et al. Microvesicular steatosis, hemosiderosis and rapid development of liver cirrhosis in a patient with Pearson's syndrome. J Hepatol 1999;31:550-555
27. Majander A, Suomalainen A, Vettenranta K, et al. Congenital hypoplastic anemia, diabetes, and severe renal tubular dysfunction associated with a mitochondrial DNA deletion. Pediatr Res 1991;30:327-330
28. Cormier-Daire V, Bonnefont JP, Rustin P, et al. Mitochondrial DNA rearrangement with onset as chronic diarrhea with villous atrophy. J Pediatr 1994;124:63-70
29. Singleton R, Helgerson SD, Snyder RD, et al. Neuropathy in Navajo children: clinical and epidemiologic features. Neurology 1990;40:363-367
30. Robinson BH. Lactic acidemia and mitochondrial disorders. Mol Genet Metab 2006;89:3-13
31. Kreisberg RA. Glucose-lactate inter-relations in man. N Engl J Med 1972;287:132-137
32. Rustin P, Chretien D, Bourgeron T, et al. Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta 1994;228:35-51
33. Holt IJ, Harding AE, Morgan-Hughes JA. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988;331:717-719
34. Cormier V, Rustin P, Bonnefont JP, et al. Hepatic failure in disorders of oxidative phosphorylation with neonatal onset. J Pediatr 1991;119:951-954
35. Bohm M, Pronicka E, Karczmarewicz E, et al. Retrospective, multicentric study of 180 children with cytochrome c oxidase deficiency. Pediatr Res 2006;59:21-26
36. Taanman JW. Human cytochrome c oxidase: structure, function, and deficiency. J Bioenerg Biomembr 1997;29:151-163
37. Valnot I, Osmond S, Gigarel N, et al. Mutations of the SCO1 gene in mitochondrial cytochrome c oxidase deficiency with neonatal-onset hepatic failure and encephalopathy. Am J Hum Genet 2000;67:1104-1109
38. Sacconi S, Salviati L, Sue CM, et al. Mutation screening in patients with isolated cytochrome c oxidase deficiency. Pediatr Res 2003;53:224-230
39. De Lonlay P, Valnot I, Barrientos A, et al. A mutant mitochondrial respiratory chain assembly protein causes complex III deficiency in patients with tubulopathy, encephalopathy and liver failure. Nat Genet 2001;29:57-60
40. De Meirleir L, Seneca S, Damis E, et al. Clinical and diagnostic characteristics of complex III deficiency due to mutations in the BCS1L gene. Am J Med Genet A 2003;121:126-131
41. Moraes CT, Shanske S, Tritschler HJ, et al. mtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases. Am J Hum Genet 1991;48:492-501
42. Jullig M, Eriksson S. Mitochondrial and submitochondrial localization of human deoxyguanosine kinase. Eur J Biochem 2000;267:5466-5472
43. Wang L, Munch-Petersen B, Herrstrom Sjoberg A, et al. Human thymidine kinase 2: molecular cloning and characterisation of the enzyme activity with antiviral and cytostatic nucleoside substrates. FEBS Lett 1999;443:170-174
44. Mandel H, Szargel R, Labay V, et al. The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat Genet 2001;29:337-341
45. Saada A, Shaag A, Mandel H, Nevo Y, Eriksson S, Elpeleg O. Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat Genet 2001;29:342-344
46. Salviati L, Sacconi S, Mancuso M, et al. Mitochondrial DNA depletion and dGK gene mutations. Ann Neurol 2002;52:311-317
47. Ferrari G, Lamantea E, Donati A, et al. Infantile hepatocerebral syndromes associated with mutations in the mitochondrial DNA polymerase-γA. Brain 2005;128:723-731
48. Horvath R, Hudson G, Ferrari G, et al. Phenotypic spectrum associated with mutations of the mitochondrial polymerase γ gene. Brain 2006;129:1674-1684
49. Spinazzola A, Viscomi C, Fernandez-Vizarra E, et al. MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion. Nat Genet 2006;38:570-575
50. Naviaux RK, Nguyen KV. POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion. Ann Neurol 2004;55:706-712
51. Nguyen KV, Sharief FS, Chan SSL, Copeland WC, Naviaux RK. Molecular diagnosis of Alpers syndrome. J Hepatol 2006;45:108-116
52. Kaguni LS. DNA polymerase γ: the mitochondrial replicase. Annu Rev Biochem 2004;73:293-320
53. Naviaux RK, Nyhan WL, Barshop BA, et al. Mitochondrial DNA polymerase gamma deficiency and mtDNA depletion in a child with Alpers' syndrome. Ann Neurol 1999;45:54-58
54. Lamantea E, Tiranti V, Bordoni A, et al. Mutations of mitochondrial DNA polymerase gammaA are a frequent cause of autosomal dominant or recessive progressive external ophthalmoplegia. Ann Neurol 2002;52:211-219
55. Vu TH, Tanji K, Holve SA, et al. Navajo neurohepatopathy: a mitochondrial DNA depletion syndrome? Hepatology 2001;34:116-120
56. Karadimas CL, Vu TH, Holve SA, et al. Navajo neurohepatopathy is caused by a mutation in the MPV17 gene. Am J Hum Genet 2006;79:544-548
57. Rotig A, Cormier V, Blanche S, et al. Pearson's marrow-pancreas syndrome: a multisystem mitochondrial disorder in infancy. J Clin Invest 1990;86:1601-1608
58. Sano T, Ban K, Ichiki T, et al. Molecular and genetic analyses of two patients with Pearson's marrow-pancreas syndrome. Pediatr Res 1993;34:105-110
59. Jacobs LJAM, Jongbloed RJE, Wijburg FA, et al. Pearson syndrome and the role of deletion dimers and duplications in the mtDNA. J Inherit Metab Dis 2004;27:47-55
60. MITOMAP. A Human Mitochondrial Genome Database. Atlanta, GA: Center for Molecular Medicine, Emory University; Available at: www.mitomap.org. Accessed October 24, 2006
61. Muraki K, Sakura N, Ueda H, Kihara H, Goto Y. Clinical implications of duplicated mtDNA in Pearson syndrome. Am J Med Genet 2001;98:205-209
62. Gillis LA, Sokol RJ. Gastrointestinal manifestations of mitochondrial disease. Gastroenterol Clin North Am 2003;32:789-817
63. Chinnery P, Majamaa K, Turnbull D, Thorburn D. Treatment for mitochondrial disorders (review). Cochrane Database Syst Rev 2006;(1):CD004426
64. Mahoney DJ, Parise G, Tarnopolsky MA. Nutritional and exercise-based therapies in the treatment of mitochondrial disease. Curr Opin Clin Nutr Metab Care 2002;5:619-629
65. Hart PE, Lodi R, Rajagopalan B, et al. Antioxidant treatment of patients with Freidreich ataxia: four year follow-up. Arch Neurol 2005;62:621-626
66. Eleff S, Kennaway NG, Buist NR, et al. 31P NMR study of improvement in oxidative phosphorylation by vitamin K3 and C in a patient with a defect in electron transport at complex III in skeletal muscle. Proc Natl Acad Sci USA 1984;81:3529-3533
67. Chen RS, Huang CC, Chu NS. Coenzyme Q10 treatment in mitochondrial encephalomyopathies: short-term double-blind, crossover study. Eur Neurol 1997;37:212-218
68. Muller W, Reimers CD, Berninger T, et al. Coenzyme Q10 in ophthalmoplegia plus: a double blind, cross over therapeutic trial. J Neurol Sci 1990;98(suppl):442
69. Frei B, Kim MC, Ames BN. Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations. Proc Natl Acad Sci USA 1990;87:4879-4883
70. Rodriguez MC, MacDonald JR, Mahoney DJ, Parise G, Beal MF, Tarnopolsky MA. Beneficial effects of creatinine, CoQ(10), and lipoic acid in mitochondrial disorders. Muscle Nerve 2007;35:235-242
71. Rustin P, Bonnet D, Rotiq A, Munnich A, Sidi D. Idebenone treatment in Freidreich patients: one-year-long randomized placebo-controlled trial. Neurology 2004;62:524-525
72. Di Rocco M, Lamba LD, Minniti G, Caruso U, Naito E. Outcome of thiamine treatment in a child with Leigh disease due to thiamine-responsive pyruvate dehydrogenase deficiency. Eur J Paediatr Neurol 2000;4:115-117
73. Bugiani M, Lamantea E, Invernizzi F, et al. Effects of riboflavin in children with complex II deficiency. Brain Dev 2006;28:576-581
74. Stacpoole PW, Kerr DS, Barnes C, et al. Controlled clinical trial of dichloroacetate for treatment of congenital lactic acidosis in children. Pediatrics 2006;117:1519-1531
75. Oguro H, Iijima K, Takahashi K, et al. Successful treatment with succinate in a patient with MELAS. Intern Med 2004;43:427-431
76. Schols L, Zange J, Abele M, et al. L-carnitine and creatine in Freidreich's ataxia: a randomized, placebo-controlled cross-over trial. J Neural Transm 2005;112:789-796
77. Kornblum C, Schroder R, Muller K, et al. Creatine has no beneficial effect on skeletal muscle energy metabolism in patients with single mitochondrial DNA deletions: a placebo-controlled, double-blind 31P-MRS crossover study. Eur J Neurol 2005;12:300-309
78. Mowat D, Kirby DM, Kamatu KR, Kan A, Thorburn DR, Christodoulou J. Respiratory chain complex III deficiency with pruritus, a novel vitamin responsive clinical feature. J Pediatr 1999;134:352-354
79. Sokal EM, Sokol R, Cormier V, et al. Liver transplantation in mitochondrial respiratory chain disorders. Eur J Pediatr 1999;158(suppl 2):S81-S84
80. Thomson M, McKiernan P, Buckels J, Mayer D, Kelly DA. Generalised mitochondrial cytopathy is an absolute contraindication to orthotopic liver transplant in childhood. J Pediatr Gastroenterol Nutr 1998;26:478-481
81. Dubern B, Broue P, Dubinsson C, et al. Orthotopic liver transplantation for mitochondrial respiratory chain disorders: a study of 5 children. Transplantation 2001;71:633-637
82. Delarue A, Paut O, Guys J-M, et al. Inappropriate liver transplantation in a child with Alpers-Huttenlocher syndrome misdiagnosed as valproate-induced acute liver failure. Pediatr Transplant 2000;4:67-71
83. Cholestatic Liver Disease Consortium (CLiC). Available at: http://rarediseasesnetwork.epi.usf.edu/chc/index.htm. Accessed February 4, 2007